stanley_rnyron_kederski, tagetlocman , portsrnouthohio (on double secret probation) , rii_666, elmaestro111, kathycronkite ,crecy_wart_knight, cathycronkite, mercury7astro, harvardphd1972, donnatello465, harvardmba1972, zoom69zoom, bobkidder89 AND of course the WORST OFFENDER IS ri66, supposedly a long who posts the same mindless $h.it all frigin day.
If you go to ACAD on the Nasdaq site and click Short Interest- you will see the present stats-
Settlement Date 4/15/2015 Short Interest 15,101,510 Avg Daily Share Volume 1,747,902.
Days To Cover 8.639792.
But take a closer look at the trend of " Days to Cover ", gradually lower and lower over the last 1 yr. It had gotten as high as 21.511967 days last Aug. Also, there is a blue inconspicuous chart to the right showing the downward trend of Days to Cover heading towards lower numbers. It goes up & down , but the general trend is FEWER DAYS TO COVER. Just an observation.
The Phases of Shorts 1) Boastful about their position,(how much they sold or shorted, "glad I sold" type of B$ ) 2) Unsubstantiated information of any kind 3) Screaming 4) quiet COVERING.
The question that should be asked is how does this relate to a potential Buy Out of ACAD ?
How did ALXN arrive at the $8.4 Billion dollar price tag for a rare disease treatment ? Did they Over Pay? If GEVA is worth 8.4 Billion how much is ACAD worth?
You based your initial position on a chart pattern ( H&S) that has already failed. Well, I watched and learned you are losing your buns. This is the very reason I never placed you on IGNORE- I use you as a gauge. You will never convince anyone that Acadia is at risk by just calling us names. You have to have FACTS...ever heard of that? Our belief in the company is sound, based on Scientific studies already reviewed by the FDA. And you have....what a "life ". Is that it? And btw the only money you will ever take from any long on this board is the 2 dollar tip to park our new cars.
It was basically what I expected..., bottom line- moving forward at a reasonable speed. Explanation of all the processes.
Phases of SHORTS 1) boasting your short position ...you already did that....2) posting unsubstantiated messages. You already did that...your failed Head & Shoulder pattern. 3) Screaming ...thats where you are NOW, whats next ....4) Quiet COVERING.
If you say it more maybe even you will believe your own prediction.
He is an excellent gauge of the shorts very weak attack - watch his posts, note how weak they are, they are empty , no facts, no basis for his reasoning. This is what the shorts have = NOTHING. Now if he starts to get obnoxious then be my guest and hit Iggy.
Are you new to this board? I don't recall seeing your posts before. I would just like to mention could you please refrain from posting over and over again to shorts and dimwits. It just clutters up the board. Its a request. None of us care about them, many of us longs already have these idiots on IGNORE. We know who they are. So there is no need to post about them. You are just playing into their hands. Please, would you mind just placing them on IGNORE. I would really appreciate it. Sincerely CWK
As i said it was a request. I even said please. Its "Freedom of Speech", not "Freedom of Speech without Consequences". You are a fellow long and I just thought you might take my request to heart. If not so be it.
I appreciate your support. I am in Pueblo, Colorado for the weekend. So I am not sure how much fun I can have...Its a slow town, but they have a great memorial-Pueblo Medal of Honor Memorial at Pueblo Convention Center.
NUPLAZID/Pimavanserin is ONE OF A KIND, FIRST IN ITS CLASS drug to treat Parkinson's Disease Psychosis (PDP). And ACAD owns the World Wide Rights to it. The FDA has already reviewed the Phase3 research data and given ACAD thumbs up to proceed with the New Drug Application and has given Pima " Breakthrough Therapy Designation " USA sales will be over 1.1 BILLION and European Union will be well over a Billion as well. There are several other ongoing studies.. The manufacturing arm of the NDA is getting the close attention it should of had last year- it will take some time for new directors & CMO 's to get the systems ready & on line for the FDA evaluations. ..Review the catalyst list-
1) New CEO who can led us to Drug Approval and move the company forward.
2) Possible Partnership with a MAJOR drug company that will assure the NDA will meet and exceed all the FDA standards.
3) NDA on track to be submitted in the 2nd half of 2015. NDA is complete, manufacturing quality systems on track.
3) 60 days for the FDA (Food and Drug Administration ) to accept the application by about Q1 2016.
4) Upon potential acceptance, FDA could also grant priority review.
5) With priority review, six months pdufa date (Prescription Drug User Fee Act ), without, 10 months. Best guess is July to Oct 2016.
6) EU ( European Union ) filing 6- 9 months post FDA filing. Perhaps Q2-3 2016. Large unmet need in EU.
7) ADP enrollment (019 study) complete by 2015 Q4 and data by about Q2 2016
8) Schizophrenia maintenance trial to commence 2nd half of 2015.
9) Sleep Study to begin 2nd half of 2015.
There are NO ongoing issues with the FDA.
So how much could they make ?
1000000 PD patients...approx 40% will get PDP. So thats 400,000 PDP patients. Price for Abilify is 13K/year...I think NUPLAZID will be higher...guess is $15,000/yr ( ~ $40/day). Now lets say of those 400,000 patients, only 20% get placed on Nuplazid first year. That's 80,000 patients on treatment....so 80,000 x $15,000/yr, so for the first year, we are talking 1.2 Billion with only 20% penetration. Remember , this does not take into consideration OFF LABEL use for any other condition or if /when it may get an indication for another type of psychosis/ sleep issue/ Autism etc. Now consider there are 1.6 million PD patiens in the EU, and 640,000 will get PDP at some point. We are talking way over a Billion in the EU also.
Well its not what I want per se - I think its a possibility for any developing company to partner. There are some big companies that already have manufacturing & distribution systems up and producing drugs in the USA and all over the world. It aint cheap and not easy to start that up from scratch. Not to mention you have to develop the connections to get things done. It might not happen , Acadia may try to go it alone, but it will take more time and big bucks.